Non-invasive advanced image analysis could lead to better patient care
TGen, Scottsdale Healthcare, and Cancer Centers of America are leading new research studies for patients suffering with lung cancer.
Method for validating radiobiological samples using a linear accelerator
Abstract There is an immediate need for rapid triage of the population in case of a large scale exposure to ionizing radiation. Knowing the dose absorbed by the body will allow clinicians to administer medical treatment for the best chance… Read More
Imaging Endpoints develops predictor of response for Tracon Pharmaceuticals
SAN DIEGO (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a biopharmaceutical company that develops targeted therapies for oncology and ophthalmology, today announced data being presented on TRC105 during two poster presentations at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer… Read More
Imaging Endpoints’ Expertise in Molecular Imaging Highlighted in Imaging Economics
With the push for integrative health and collaborative care, now more than ever radiologists are serving in roles that transcend pure diagnostician. In an oncology specialty that espouses a multimodality, team-based approach, imaging is poised to fulfill, and go beyond,… Read More
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer’s disease dementia, mild cognitive impairment, and normal aging
Abstract Objective To evaluate the performance characteristics of florbetapir F18 positron emission tomography (PET) in patients with Alzheimer's disease (AD), mild cognitive impairment (MCI), and healthy control subjects (HCs). Methods Florbetapir PET was acquired in 184 subjects (45 AD patients,… Read More
